Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for extubation success in ICU patients with head trauma
IRCT20240929063203N6Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in laryngeal edema comparing Hydrocortisone with Placebo normal saline (2 arms). Primary endpoint: Success rate of endotracheal tube removal. Started Apr 2026; status: completed.
02
Drugs
hydrocortisone
03
Conditions
laryngeal edema
Beyond the preview
Go deeper on IRCT20240929063203N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240929063203N6.